Fundraising FoxFl2021-001
San Francisco, US · Founded 2021 · Delaware corporation · 2 known investors
Find your way into Fl2021-001
Sign up to see every warm intro you have to Fl2021-001
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fl2021-001 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JL
June LeeNamed on SEC filing
Board
JT
VB
Investors · 2
Reported raises · per SEC filings
Form D private placements$240M disclosed across 4 rounds · 2021–2024
▶$40MraisedJul 2024 · 1 investors · BiotechnologyRule 506(b)
▶$40MraisedJul 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Srinivas AkkarajuDirector
- John R. SchroerExecutive Officer
- James TananbaumDirector
- Derrick RichardsonExecutive Officer
- Patrick MachadoDirector
- Sapna SrivastavaDirector
- Martin BablerExecutive Officer, Director
- Mark BradleyExecutive Officer
- Zhengbin YaoDirector
- Sara KleinExecutive Officer
- David M. GoldsteinExecutive Officer
- Jorn DrappaExecutive Officer
- Alan B. ColowickDirector
- Roy C. HardimanExecutive Officer
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$129.5MraisedMar 2024 · 24 investors · BiotechnologyRule 506(b)
▶$129.5MraisedMar 2024 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard GasterDirector
- Zhengbin YaoDirector
- Sapna SrivastavaDirector
- Martin BablerExecutive Officer, Director
- Alan ColowickDirector
- Julian BakerDirector
- James TananbaumDirector
- Srinivas AkkarajuDirector
- Offering amount
- $259M
- Amount sold
- $129.5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$60MraisedMar 2021 · 3 investors · Other Health CareRule 506(b)
▶$60MraisedMar 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- June LeeExecutive Officer, Director
- James TananbaumDirector
- Michael RomeDirector
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$10.5MraisedFeb 2021 · 3 investors · Other Health CareRule 506(b)
▶$10.5MraisedFeb 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James TananbaumDirector
- June LeeExecutive Officer, Director
- Vikram BajajDirector
- Offering amount
- $10.5M
- Amount sold
- $10.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Fl2021-001's investors?
- Fl2021-001's investors include Foresite Capital, Samsara BioCapital.
- How much funding has Fl2021-001 raised?
- Fl2021-001 has disclosed $240M raised across 4 rounds.
- Where is Fl2021-001 headquartered?
- Fl2021-001 is headquartered in San Francisco, US.